-
Implementing SISAQOL Recommendations: Insights From Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
A Cost-Utility Analysis of Ferric Derisomaltose vs. Ferric Carboxymaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease in the United Kingdom: Accounting for Difference in Fracture Risk
Sep 9, 2025, 16:22 PM -
Impact of the Societal Perspective on HTA Decision Making in Rare Diseases
Sep 9, 2025, 16:22 PM -
Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns and Outcomes in First-Line Small-Cell Lung Cancer (SCLC) in France
Sep 9, 2025, 16:22 PM -
Describing the Burden of RSV Infection and Subsequent Wheezing in Toddlers: An International Cross-Sectional Study
Sep 9, 2025, 16:22 PM -
Comparing Individualized Treatment Effect Inference Methods Through a Simulation Study
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Firstline Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review With Focus on the PD-L1 Negative Subgroup
Sep 9, 2025, 16:22 PM -
Chronic Kidney Disease in Type-2 Diabetes Patients: A Population-Based Descriptive Study
Sep 9, 2025, 16:22 PM -
Disease-Free Survival as a Surrogate Endpoint for Overall Survival in Patients With Adjuvant Treatments for Completely Resected Stage I-III Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses
Sep 9, 2025, 16:22 PM -
Real-World Outcomes and Economic Impact of Ribociclib in HR+/HER2- Advanced Breast Cancer: Evidence From the Portuguese REASSURE Cohort
Sep 9, 2025, 16:22 PM -
Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures
Sep 9, 2025, 16:22 PM -
Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France
Sep 9, 2025, 16:22 PM -
Budget and Time Impact Analysis of Introducing Subcutaneous Pembrolizumab to Patients From Institution HCP and Patient Perspectives in the United States (US)
Sep 9, 2025, 16:22 PM -
Estimand Framework in the Setting of Observational Studies: Current Landscape and Future Directions
Sep 9, 2025, 16:22 PM -
Overcoming Patient Access Barriers in Complex Conditions: Lessons From Schizophrenia for Broader Healthcare Applications
Sep 9, 2025, 16:22 PM -
Efficient and High-Quality Decision Making: An Exploration of Disease-Specific Reference Models at NICE
Sep 9, 2025, 16:22 PM -
Quantifying the Impact of Inconsistencies in Economic Modeling Assumptions: A Case Study in Metastatic Colorectal Cancer
Sep 9, 2025, 16:22 PM -
Economic Assessments of Rare Disease Drugs in France: Insights From CEESP Opinions Reviews
Sep 9, 2025, 16:22 PM -
Systematic Literature Review of Artificial Intelligence-Based Models Predicting COPD Exacerbations
Sep 9, 2025, 16:22 PM
